Supporting Treatment Access and Recovery in Re-entry (STAR-R)

Summary

This application is aimed at testing a multicomponent intervention called "Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice (MISSION-CJ) or Peer Linkage Support post-release from two jails in Massachusetts for individuals with co-occurring substance use and mental health disorders (COD), given high rates of COD among incarcerated populations. The research will examine engagement in treatment, behavioral health outcomes, mediators and moderators, an economic analysis, and facilitators and barriers of MISSION-CJ implementation.

Conditions

• Mental Health
• Substance Use Disorders
• Co-occurring Mental and Substance Use Disorders

Interventions

BEHAVIORAL

Full MISSION-CJ

MISSION-CJ is a time-limited, cross disciplinary, team-based wraparound approach that provides 6 months of psychosocial treatment combined with assertive outreach, empowering clients to access and engage in care and community services to promote recovery and address criminogenic risk. The MISSION-CJ treatment curriculum integrates 3 evidence-based practices: 1) Critical Time Intervention (CTI), a time-limited form of assertive community treatment; 2) Dual Recovery Therapy (DRT), which is integrated mental health and substance use group therapy; and 3) Peer Support (PS), offering support for people in recovery by people in recovery.

BEHAVIORAL

Peer Linkage Support

Linkage only is provided via Peer Specialists whom have lived experiences similar to that of our participants. Linkage only includes informal treatment planning and linkages and supports to needed community services.

Sponsors & Collaborators

• Cornell University

  collaborator OTHER

• National Institute on Drug Abuse (NIDA)

  collaborator NIH

• University of Massachusetts, Worcester

  lead OTHER

Principal Investigators

• David Smelson, PsyD · University of Massachusetts, Worcester

• Paige Shaffer, PhD · University of Massachusetts, Worcester

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2026-05-01

Primary Completion

2030-05-31

Completion

2030-08-31

Countries

• United States

Study Locations